BISMUTH SUBSALICYLATE SUSPENSION
Google image searchProduct monograph
Active ingredient
bismuth subsalicylate, 17.5 MG/ML
DIN: 02313162
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: OTC
Company: GUARDIAN DRUG COMPANY INC
Date: 05-NOV-2021
ATC:
- A07 — ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (ATC, ATC/DDD, )
- A07B — INTESTINAL ADSORBENTS (ATC, ATC/DDD)
- A07BB — Bismuth preparations (ATC, ATC/DDD)
Pharmaceutical standard: USP
